Mustang Bio (MBIO) Financials

$0.53

$-0.01 (-2.42%)

As on 09-Sep-2026 16:00EDT

Market cap

$4 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

0.6

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	--	--	--	--	--	--
Cost of Revenue	--	0.04	0.82	2.23	3.03	2.31
Gross Profit	--	-0.04	-0.82	-2.23	-3.03	-2.31
Operating Expenses	3.52	2.39	16.25	48.50	73.13	64.42
Operating Profit (EBIT)	-3.52	-2.43	-16.25	-50.73	-76.16	-66.72
Other Income	--	--	--	--	--	--
Profit before Tax	-3.03	-1.92	-15.75	-51.60	-77.53	-66.37
Provision for Tax	--	--	-15.75	--	1.37	-2.29
Profit after Tax (Net Income)	-3.03	-1.92	-15.75	-51.60	-77.53	-66.37
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-77.53	-66.37

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	7.55	9.53	-3.87	0.12	46.27	112.40
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	0.15	0.15	0.57	2.25	31.04	1.96
Current Liabilities	7.92	7.91	12.61	15.37	15.11	10.82
Total Liabilities	23.53	17.59	9.31	17.74	92.42	125.17

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	--	--	0.70	6.40	13.57	13.46
Current Assets	15.61	17.59	8.61	11.35	78.85	111.71
Total Assets	23.53	17.59	9.31	17.74	92.42	125.17
Total Debt*	--	--	0.88	2.50	31.38	2.03
Net Current Assets	7.70	9.68	-4.00	-4.03	63.74	100.89

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-5.26	-11.41	-49.48	-65.07	-53.67
Cash Flow from Investing Activities	--	1.17	--	5.89	-2.95	-5.37
Cash from Financing Activities	--	14.53	11.27	-26.08	34.06	70.85
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-0.45	-0.26	-1.81	-5.60	-10.83	-11.33
Cash EPS ($)	--	-0.26	-1.72	-5.30	-10.41	-10.93
Adjusted Book Value ($)	--	1.31	--	0.01	6.47	19.18
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.72	-1.31	-5.37	-9.09	-9.16
Free Cash Flow per Share ($)	--	-0.72	-1.31	-5.38	-9.52	-10.08

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-58.80	8,423.53	-128.56	-80.72	-61.71
ROE (%)	-35.53	-67.93	840.11	-222.44	-97.72	-62.96
ROA (%)	-13.02	-14.28	-116.47	-93.68	-71.26	-56.47
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	--	--	--	--	--	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	--	87.80	68.69	32.20	-11.77	-18.28
Net Profit Growth (%)	7.45	87.80	69.47	33.44	-16.81	-10.59
EPS Growth (%)	-5.61	0.85	0.68	0.48	0.04	0.34
Book Value Growth (%)	131.78	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-3.73	-0.10	-0.24	-0.04	-0.15
Price / Book Value	0.55	0.75	-0.40	101.20	0.06	0.09
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-0.14	5.38	0.30	-0.18	0.58	1.53
Close Price ($)	0.70	0.98	8.85	67.50	296.18	1,245.00
High Price ($)	7.00	21.95	76.50	554.18	1,376.25	3,915.00
Low Price ($)	0.53	0.89	6.41	60.50	236.25	1,215.00
Market Cap ($ Cr)	4.11	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	--	-0.23	20.31	0.68	0.02
Short term debt to equity ratio	--	--	-0.12	4.23	0.01	0.00
Current Ratio	1.97	2.22	0.68	0.74	5.22	10.33
Quick Ratio	1.97	--	--	--	--	--
Interest Coverage	--	--	-3,149.40	-38.27	-22.08	-4,423.67

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	48,881.14	3,059.14	1,079.74	623.31	556.74
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.